Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs

被引:31
|
作者
Winograd, Rachel P. [1 ]
Wood, Claire A. [1 ]
Stringfellow, Erin J. [1 ]
Presnall, Ned [2 ]
Duello, Alex [1 ]
Horn, Phil [1 ]
Rudder, Tim [3 ]
机构
[1] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle Dr, St Louis, MO 63134 USA
[2] Washington Univ, Dept Psychiat, 1 Brookings Dr, St Louis, MO 63130 USA
[3] Missouri Dept Mental Hlth, 1706 East Elm St, Jefferson City, MO 65101 USA
关键词
Opioid use disorder; Buprenorphine; Substance use treatment; State targeted response; LONG-TERM OUTCOMES; ASSISTED TREATMENT; BUPRENORPHINE TREATMENT; MAINTENANCE THERAPY; COUNSELOR ATTITUDES; UNITED-STATES; CARE; DEPENDENCE; BARRIERS; DISCONTINUATION;
D O I
10.1016/j.jsat.2019.06.015
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Leaders of Missouri's State Targeted Response to the opioid crisis (STR) grant have prioritized increasing access to treatment medications for opioid use disorder (MOUD) through a "Medication First" approach. This conceptual framework prioritizes rapid, sustained, low-barrier access to MOUD for optimal impact on decreased illicit drug use and mortality. Medication First principles and practices were facilitated through state-level structural changes and disseminated to participating community treatment programs via a multi-pronged, multi-disciplinary approach. In the first nine months of STR, 14 state-contracted treatment agencies operating 38 sites used STR funding to implement the Medication First model. Methods: We utilized state billing and service data to make comparisons before and during STR on the following outcomes: MOUD utilization, timely access to MOUD, amount of psychosocial services delivered, treatment retention at 1, 3, and 6 months, and monthly price of treatment. We conducted follow-up analyses examining differences across MOUD types (no medication, methadone, buprenorphine, oral naltrexone, mixed antagonist + agonist, and extended release naltrexone). Results: During STR, MOUD utilization increased (44.8% to 85.3%), timeliness of MOUD receipt improved (Median of 8 days vs. 0 days), there were fewer psychosocial services delivered, treatment retention improved at one, three, and six month timeframes, and the median cost per month was 21% lower than in the year prior to STR. All differences were driven by increased utilization of buprenorphine. Conclusions: Findings suggest Medication First implementation through STR was successful in all targeted domains. Though much more work is needed to further reduce logistical, financial, and cultural barriers to improved access to maintenance MOUD, the steps taken through Missouri's STR grant show significant promise at making swift and drastic transformations to a system of care in response to a growing public health emergency.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 50 条
  • [1] The Transition to Medication Adoption in Publicly Funded Substance Use Disorder Treatment Programs: Organizational Structure, Culture, and Resources
    Knudsen, Hannah K.
    Roman, Paul M.
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2014, 75 (03) : 476 - 485
  • [2] It's not just the money: The role of treatment ideology in publicly funded substance use disorder treatment
    Stewart, Rebecca E.
    Wolk, Courtney Benjamin
    Neimark, Geoffrey
    Vyas, Ridhi
    Young, Jordyn
    Tjoa, Chris
    Kampman, Kyle
    Jones, David T.
    Mandell, David S.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 120
  • [3] The case for a medication first approach to the treatment of opioid use disorder
    Winograd, Rachel P.
    Presnall, Ned
    Stringfellow, Erin
    Wood, Claire
    Horn, Phil
    Duello, Alex
    Green, Lauren
    Rudder, Tim
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04): : 333 - 340
  • [4] Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California
    Krebs, Emanuel
    Enns, Benjamin
    Evans, Elizabeth
    Urada, Darren
    Anglin, M. Douglas
    Rawson, Richard A.
    Hser, Yih-Ing
    Nosyk, Bohdan
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (01) : 10 - +
  • [5] The first five years of implementing Missouri's medication first approach to opioid use disorder treatment: Plateaus, regressions, and underbellies of progress
    Winograd, Rachel P.
    Park, Brandon
    Coffey, Bridget
    Ghonasgi, Rashmi
    Blanchard, Brittany
    Thater, Paul
    Brown, Katherine C.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2025, 170
  • [6] IMPLEMENTATION OF MEDICATION TREATMENT FOR OPIOID USE DISORDER IN CORRECTIONAL SETTINGS
    Bandara, Sachini
    Kennedy-Hendricks, Alene
    Merritt, Sydney
    Barry, Colleen
    Eisenberg, Matthew
    Rabideau, Brendan
    Saloner, Brendan
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S169 - S169
  • [7] Bridging to Better Substance Use Treatment: Implementation and Effectiveness of Statewide Emergency Department Opioid Use Disorder Treatment Programs in California
    Samuels, E.
    Rosen, A.
    Kaleekal, J.
    Speener, M.
    Campbell, A.
    Moulin, A.
    Herring, A.
    ANNALS OF EMERGENCY MEDICINE, 2023, 82 (04) : S38 - S38
  • [8] Organizing Publicly Funded Substance Use Disorder Treatment in the United States: Moving Toward a Service System Approach
    Padwa, Howard
    Urada, Darren
    Gauthier, Patrick
    Rieckmann, Traci
    Hurley, Brian
    Crevecouer-MacPhail, Desiree
    Rawson, Richard A.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2016, 69 : 9 - 18
  • [9] Medication Treatment of Opioid Use Disorder
    Bell, James
    Strang, John
    BIOLOGICAL PSYCHIATRY, 2020, 87 (01) : 82 - 88
  • [10] Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities
    Mojtabai, Ramin
    Mauro, Christine
    Wall, Melanie M.
    Barry, Colleen L.
    Olfson, Mark
    HEALTH AFFAIRS, 2019, 38 (01) : 14 - 23